A set of microRNAs coordinately controls tumorigenesis, invasion, and metastasis

MicroRNA-mediated gene regulation has been implicated in various diseases, including cancer. This study examined the role of microRNAs (miRNAs) during tumorigenesis and malignant progression of pancreatic neuroendocrine tumors (PanNETs) in a genetically engineered mouse model. Previously, a set of m...

Full description

Saved in:
Bibliographic Details
Published inProceedings of the National Academy of Sciences - PNAS Vol. 116; no. 48; pp. 24184 - 24195
Main Authors Michael, Iacovos P., Saghafinia, Sadegh, Hanahan, Douglas
Format Journal Article
LanguageEnglish
Published United States National Academy of Sciences 26.11.2019
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:MicroRNA-mediated gene regulation has been implicated in various diseases, including cancer. This study examined the role of microRNAs (miRNAs) during tumorigenesis and malignant progression of pancreatic neuroendocrine tumors (PanNETs) in a genetically engineered mouse model. Previously, a set of miRNAs was observed to be specifically up-regulated in a highly invasive and metastatic subtype of mouse and human PanNET. Using functional assays, we now implicate different miRNAs in distinct phenotypes: miR-137 stimulates tumor growth and local invasion, whereas the miR-23b cluster enables metastasis. An algorithm, Bio-miRTa, has been developed to facilitate the identification of biologically relevant miRNA target genes and applied to these miRNAs. We show that a top-ranked miR-137 candidate gene, Sorl1, has a tumor suppressor function in primary PanNETs. Among the top targets for the miR-23b cluster, Acvr1c/ALK7 has recently been described to be a metastasis suppressor, and we establish herein that it is down-regulated by the miR-23b cluster, which is crucial for its prometastatic activity. Two other miR-23b targets, Robo2 and P2ry1, also have demonstrable antimetastatic effects. Finally, we have used the Bio-miRTa algorithm in reverse to identify candidate miRNAs that might regulate activin B, the principal ligand for ALK7, identifying thereby a third family of miRNAs—miRNA-130/301—that is congruently up-regulated concomitant with down-regulation of activin B during tumorigenesis, suggestive of functional involvement in evasion of the proapoptotic barrier. Thus, dynamic up-regulation of miRNAs during multistep tumorigenesis and malignant progression serves to down-regulate distinctive suppressor mechanisms of tumor growth, invasion, and metastasis.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Contributed by Douglas Hanahan, October 9, 2019 (sent for review August 5, 2019; reviewed by Eduard Batlle and Andrea Ventura)
Author contributions: I.P.M. and D.H. designed research; I.P.M. and S.S. performed research; I.P.M. and S.S. contributed new reagents/analytic tools; I.P.M. and S.S. analyzed data; and I.P.M. and D.H. wrote the paper.
Reviewers: E.B., Institut de Recerca en Biomedicina Barcelona; and A.V., Memorial Sloan Kettering Cancer Center.
ISSN:0027-8424
1091-6490
DOI:10.1073/pnas.1913307116